Global Glycosyltransferase Market, By Product (Instruments, Kits, Carbohydrates, Reagents and Chemicals), Application (Drug Discovery and Development, Disease Diagnostics, Other Applications), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories) – Industry Trends and Forecast to 2029.
Glycosyltransferase Market Analysis and Size
The market for glycosyltransferase is expected to grow in the forecast region of 2022-2029. The increase in market size is attributed to a number of factors, including rising biologics consumption, tentative approval of late-stage molecules, the development of novel therapies using cutting-edge technologies, and an increase in the number of people seeking treatment due to improved diagnostic tools.
Data Bridge Market Research analyses that the glycosyltransferase market which is expected to undergo a CAGR during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Glycosyltransferase Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Instruments, Kits, Carbohydrates, Reagents and Chemicals), Application (Drug Discovery and Development, Disease Diagnostics, Other Applications), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), New England Biolabs (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Techne (U.S.), Shimadzu Corporation (Japan), Bruker (U.S.), Chemily Glycoscience (U.S.), Dextra Laboratories Limited (U.K.), Ludger Ltd (U.K.), Promega Corporation (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Glycosyltransferases use sugar donors with a nucleoside phosphate or a lipid phosphate leaving group to catalyse the creation of glycosidic bonds. There are now more structural folds being discovered for the soluble domains of lipid phosphosugar-dependent glycosyl transferases, but just two structural folds, GT-A and GT-B, have been revealed for the nucleotide sugar-dependent enzymes. Studies on structure and kinetics have revealed novel insights.
Glycosyltransferase Market Dynamics
Drivers
- Rise in proteomics and glycomics
In the forecast period of 2022–2029, a number of factors are anticipated to favourably influence the growth of the glycosyltransferase market, including the expanding number of proteomics applications around the world, the rising volume of funding for the development of technology in glycomics instrumentation, and rising research and development activities.
- Increasing demand of medication
On the other hand, rising demand for individualised medications, applications from developing nations, and the discovery of biomarkers will all contribute to the expansion of the glycosyltransferase market throughout the time covered by the forecast.
Opportunities
The market's growth is fuelled by a rising demand for individualised medications, applications from developing nations. This will provide beneficial opportunities for the market growth.
Restraints/Challenges
- High cost of tools
Volatility in prices of tools which will hinder the growth of the glycosyltransferase market in the above mentioned forecast period.
This glycosyltransferase market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycosyltransferase market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Glycosyltransferase Market Scope
The glycosyltransferase market is segmented on the basis of product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Instruments
- Kits
- Carbohydrates
- Reagents
- Chemicals
Application
- Drug Discovery and Development
- Disease Diagnostics
- Other Applications
End User
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
Glycosyltransferase Market Regional Analysis/Insights
The glycosyltransferase market is analysed and market size insights and trends are provided by country, product, application and end-user as referenced above.
The countries covered in the glycosyltransferase market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the glycosyltransferase market due to the increasing number of research and development activities along with prevalence of various market players in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Glycosyltransferase Market Share Analysis
The glycosyltransferase market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycosyltransferase market.
Some of the major players operating in the glycosyltransferase market are:
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- New England Biolabs (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Bio-Techne (U.S.)
- Shimadzu Corporation (Japan)
- Bruker (U.S.)
- Chemily Glycoscience (U.S.)
- Dextra Laboratories Limited (U.K.)
- Ludger Ltd (U.K.)
- Promega Corporation (U.S.)
SKU-